# Cohen & Steers, Inc.: financial statements, quarterly

CNS · NYSE · CIK 1284812 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cns.md) · [Financials](/companies/cns/financials.md) · [Filings](/companies/cns/filings.md) · [Insiders](/companies/cns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cns/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [124](/filings/0001284812-24-000361.md) | [119 d](/filings/0001284812-26-000011.md) | [123](/filings/0001284812-25-000156.md) | [122](/filings/0001284812-25-000255.md) | [133](/filings/0001284812-25-000299.md) | [140 d](/filings/0001284812-26-000011.md) | [134](/filings/0001284812-26-000045.md) | [136](/filings/0001284812-26-000146.md) | [142](/filings/0001284812-25-000299.md) | [144 d](/filings/0001284812-26-000011.md) | [146](/filings/0001284812-26-000045.md) | [153](/filings/0001284812-26-000146.md) |
| Operating income | $m | [40.9](/filings/0001284812-24-000361.md) | [37.9 d](/filings/0001284812-26-000011.md) | [40.3](/filings/0001284812-25-000156.md) | [38.4](/filings/0001284812-25-000255.md) | [44.9](/filings/0001284812-25-000299.md) | [49.3 d](/filings/0001284812-26-000011.md) | [45.2](/filings/0001284812-26-000045.md) | [43.3](/filings/0001284812-26-000146.md) | [48.9](/filings/0001284812-25-000299.md) | [40.3 d](/filings/0001284812-26-000011.md) | [50.1](/filings/0001284812-26-000045.md) | [52.8](/filings/0001284812-26-000146.md) |
| Income tax | $m | [10.5](/filings/0001284812-24-000361.md) | [11.9 d](/filings/0001284812-25-000087.md) | [10.9](/filings/0001284812-24-000195.md) | [10.9](/filings/0001284812-24-000285.md) | [12.3](/filings/0001284812-24-000361.md) | [12.7 d](/filings/0001284812-25-000087.md) | not reported | [12.1](/filings/0001284812-26-000146.md) | not reported | not reported | not reported | [16.4](/filings/0001284812-26-000146.md) |
| Net income | $m | [32.1](/filings/0001284812-24-000361.md) | [29.8 d](/filings/0001284812-26-000011.md) | [34.0](/filings/0001284812-25-000156.md) | [31.8](/filings/0001284812-25-000255.md) | [39.7](/filings/0001284812-25-000299.md) | [45.8 d](/filings/0001284812-26-000011.md) | [39.8](/filings/0001284812-26-000045.md) | [36.8](/filings/0001284812-26-000146.md) | [41.7](/filings/0001284812-25-000299.md) | [34.9 d](/filings/0001284812-26-000011.md) | [42.4](/filings/0001284812-26-000045.md) | [49.3](/filings/0001284812-26-000146.md) |
| Diluted EPS | $ per share | [0.65](/filings/0001284812-24-000361.md) | not reported | [0.68](/filings/0001284812-25-000156.md) | [0.63](/filings/0001284812-25-000255.md) | [0.77](/filings/0001284812-25-000299.md) | not reported | [0.77](/filings/0001284812-26-000045.md) | [0.72](/filings/0001284812-26-000146.md) | [0.81](/filings/0001284812-25-000299.md) | not reported | [0.82](/filings/0001284812-26-000045.md) | [0.95](/filings/0001284812-26-000146.md) |
| Basic EPS | $ per share | [0.65](/filings/0001284812-24-000361.md) | not reported | [0.69](/filings/0001284812-25-000156.md) | [0.63](/filings/0001284812-25-000255.md) | [0.78](/filings/0001284812-25-000299.md) | not reported | [0.78](/filings/0001284812-26-000045.md) | [0.72](/filings/0001284812-26-000146.md) | [0.81](/filings/0001284812-25-000299.md) | not reported | [0.82](/filings/0001284812-26-000045.md) | [0.96](/filings/0001284812-26-000146.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [133](/filings/0001284812-24-000361.md) | [187](/filings/0001284812-26-000011.md) | [99.5](/filings/0001284812-25-000156.md) | [122](/filings/0001284812-25-000255.md) | [106](/filings/0001284812-25-000299.md) | [183](/filings/0001284812-26-000011.md) | [65.2](/filings/0001284812-26-000045.md) | [95.4](/filings/0001284812-26-000146.md) | [98.1](/filings/0001284812-25-000299.md) | [145](/filings/0001284812-26-000146.md) | [53.1](/filings/0001284812-26-000045.md) | [59.2](/filings/0001284812-26-000146.md) |
| Total assets | $m | [674](/filings/0001284812-23-000281.md) | [737](/filings/0001284812-25-000087.md) | [681](/filings/0001284812-24-000195.md) | [784](/filings/0001284812-24-000285.md) | [728](/filings/0001284812-24-000361.md) | [812](/filings/0001284812-26-000011.md) | [835](/filings/0001284812-25-000156.md) | [751](/filings/0001284812-25-000255.md) | [802](/filings/0001284812-25-000299.md) | [877](/filings/0001284812-26-000146.md) | [855](/filings/0001284812-26-000045.md) | [901](/filings/0001284812-26-000146.md) |
| Total liabilities | $m | [218](/filings/0001284812-23-000281.md) | [244](/filings/0001284812-25-000087.md) | [206](/filings/0001284812-24-000195.md) | [200](/filings/0001284812-24-000285.md) | [215](/filings/0001284812-24-000361.md) | [237](/filings/0001284812-26-000011.md) | [194](/filings/0001284812-25-000156.md) | [209](/filings/0001284812-25-000255.md) | [222](/filings/0001284812-25-000299.md) | [243](/filings/0001284812-26-000146.md) | [188](/filings/0001284812-26-000045.md) | [206](/filings/0001284812-26-000146.md) |
| Shareholders' equity | $m | [367](/filings/0001284812-23-000281.md) | [381](/filings/0001284812-25-000087.md) | [379](/filings/0001284812-24-000195.md) | [463](/filings/0001284812-24-000285.md) | [491](/filings/0001284812-24-000361.md) | [512](/filings/0001284812-26-000011.md) | [508](/filings/0001284812-25-000156.md) | [529](/filings/0001284812-25-000255.md) | [550](/filings/0001284812-25-000299.md) | [562](/filings/0001284812-26-000146.md) | [563](/filings/0001284812-26-000045.md) | [589](/filings/0001284812-26-000146.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [74.7 d](/filings/0001284812-24-000361.md) | [58.6 d](/filings/0001284812-26-000011.md) | [4.9](/filings/0001284812-25-000156.md) | [31.4 d](/filings/0001284812-25-000255.md) | [25.6 d](/filings/0001284812-25-000299.md) | [34.8 d](/filings/0001284812-26-000011.md) | [(109)](/filings/0001284812-26-000045.md) | [(67.6) d](/filings/0001284812-26-000146.md) | [55.1 d](/filings/0001284812-25-000299.md) | [1.1 d](/filings/0001284812-26-000011.md) | [(51.4)](/filings/0001284812-26-000045.md) | [67.4 d](/filings/0001284812-26-000146.md) |
| Capital expenditure | $m | [26.0 d](/filings/0001284812-24-000361.md) | [10.8 d](/filings/0001284812-26-000011.md) | [4.3](/filings/0001284812-25-000156.md) | [4.2 d](/filings/0001284812-25-000255.md) | [1.4 d](/filings/0001284812-25-000299.md) | [1.7 d](/filings/0001284812-26-000011.md) | [1.1](/filings/0001284812-25-000156.md) | [2.1 d](/filings/0001284812-26-000146.md) | [2.5 d](/filings/0001284812-25-000299.md) | [0.3 d](/filings/0001284812-26-000011.md) | not reported | not reported |
| Dividends paid | $m | [28.2 d](/filings/0001284812-24-000361.md) | [28.1 d](/filings/0001284812-26-000011.md) | [29.3](/filings/0001284812-25-000156.md) | [29.9 d](/filings/0001284812-25-000255.md) | [30.0 d](/filings/0001284812-25-000299.md) | [30.0 d](/filings/0001284812-26-000011.md) | [31.7](/filings/0001284812-26-000045.md) | [31.7 d](/filings/0001284812-26-000146.md) | [31.7 d](/filings/0001284812-25-000299.md) | [31.8 d](/filings/0001284812-26-000011.md) | [34.5](/filings/0001284812-26-000045.md) | [34.5 d](/filings/0001284812-26-000146.md) |
| Share repurchases | $m | [0.1 d](/filings/0001284812-24-000361.md) | [0.9 d](/filings/0001284812-26-000011.md) | [19.4](/filings/0001284812-25-000156.md) | [0.1 d](/filings/0001284812-25-000255.md) | [0.1 d](/filings/0001284812-25-000299.md) | [1.5 d](/filings/0001284812-26-000011.md) | [26.0](/filings/0001284812-26-000045.md) | [0.6 d](/filings/0001284812-26-000146.md) | [0.3 d](/filings/0001284812-25-000299.md) | [1.6 d](/filings/0001284812-26-000011.md) | [16.9](/filings/0001284812-26-000045.md) | [0.4 d](/filings/0001284812-26-000146.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.3](/filings/0001284812-23-000281.md) | [49.4](/filings/0001284812-24-000195.md) | [49.5](/filings/0001284812-24-000285.md) | [49.6](/filings/0001284812-24-000361.md) | [49.8](/filings/0001284812-25-000156.md) | [50.8](/filings/0001284812-25-000255.md) | [51.4](/filings/0001284812-25-000299.md) | [51.4](/filings/0001284812-26-000045.md) | [51.5](/filings/0001284812-26-000146.md) | [51.6](/filings/0001284812-25-000299.md) | [51.6](/filings/0001284812-26-000045.md) | [51.9](/filings/0001284812-26-000146.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,421,533 at 2026-07-23, from the cover of the [10-Q filed 2026-07-31](/filings/0001284812-26-000146.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.